MedPath

The effect of Thyme oxymel on patients with cystic fibrosis

Phase 3
Conditions
Cystic Fibrosis.
Cystic fibrosis with pulmonary manifestations
E84.0
Registration Number
IRCT20230903059345N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with cystic fibrosis
Age above 5 years
Outpatients

Exclusion Criteria

Patients less than 5 years old
Hospitalization for any reason during treatment
History of allergy to thyme, vinegar or honey
Taking systemic corticosteroids by the patient
Occurrence of special medical conditions and not using the medicine by the patient

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath